News Releases

Read all the latest news from Bristol Myers Squibb the Netherlands here.

Construction of CAR T facility in Leiden has started >
On the 28th of October, Bristol Myers Squib held a groundbreaking event at the Leiden Bio Science Park in the Netherlands to celebrate the start of the construction of its first cell therapy facility in Europe.
CAR T-celtherapiefaciliteit

Bristol Myers Squibb starts construction of its European therapy facility, at Leiden Bio Science Park >
Bristol Myers Squibb (BMS) has started the construction of its CAR T cell therapy production center at the Leiden Bio Science Park (LBSP). Leiden will be the biopharmaceutical company’s first cell therapy facility in Europe and the fifth in the world. BMS expects the facility to be operational at the end of 2024, bringing the manufacturing of its cell therapies closer to European patients. In addition, the new production facility is expected to create at least 500 new jobs.
CAR T therapy facility

Sally Ann McNab appointed as General Manager for Bristol Myers Squibb Benelux >
Sally Ann McNab takes on the general management of the Benelux organisation of the global biopharmaceutical company Bristol Myers Squibb.
Sally Ann McNab

Contact details for media

Didn't find the information you were looking for or do you have further questions? Please contact us directly. We will be happy to help you out!

 

Ronald Jager

Senior Manager Corporate Affairs

 

Phone number: +31 30 300 22 22

 

E-mail: info.nl@bms.com

 

For all other questions

If you are not a member of the press and have a non-media related question then find the right contact information here. This will enable us to help you faster!